What is a Celiac Disease Test?
A Celiac Disease Test, also known as celiac panel or celiac serology, is a diagnostic procedure used to determine whether an individual has celiac disease, an autoimmune disorder triggered by the ingestion of gluten. Gluten is a protein found in wheat, barley, and rye, and for people with celiac disease, consuming even small amounts of gluten can lead to severe gastrointestinal and systemic symptoms.
The primary purpose of a Celiac Disease Test is to identify specific antibodies in the blood that are indicative of an immune response to gluten. The three primary antibodies tested for are:
- Anti-tissue transglutaminase (tTG) antibodies: These antibodies are commonly found in individuals with celiac disease. They are produced when the immune system mistakenly targets the small intestine's lining in response to gluten consumption.
- Anti-endomysial antibodies (EMA): EMA antibodies are another marker of the autoimmune reaction in celiac disease. They target the endomysium, a connective tissue layer surrounding muscle fibers.
- Anti-deamidated gliadin peptides (DGP) antibodies: These antibodies target a component of gluten called gliadin. Elevated levels of DGP antibodies can suggest celiac disease.
A blood sample is typically collected from the patient to perform the test. If the initial blood test results suggest celiac disease, a small intestine biopsy may be recommended to confirm the diagnosis. In the biopsy, a small piece of tissue is extracted from the small intestine and examined for characteristic damage caused by the autoimmune response to gluten.
Early and accurate diagnosis of celiac disease is crucial because it allows individuals to adopt a strict gluten-free diet, the only effective treatment for the condition. Celiac disease can lead to serious health complications without proper management, including malnutrition, osteoporosis, and an increased risk of other autoimmune disorders.










